DIETARY_SUPPLEMENT · Unmapped registry intervention
carnosine
Find medicine records ·
Find other trials using this name
Clinical trial
The Potential of Carnosine Supplementation in Reducing the Cardiometabolic Risk
NCT02686996
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedThe Potential of Carnosine Supplementation in Reducing the Cardiometabolic Risk
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Insulin Sensitivityunresolved
Interventions
Sponsors & collaborators
Monash Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02686996 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.